OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128
Showing 101-125 of 128 citing articles:
An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5
Stephen A. Varvel, Marzena Galdzicka, Stephanie Nystrom, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Stephen A. Varvel, Marzena Galdzicka, Stephanie Nystrom, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Improving the Antigenicity of SARS-CoV-2 Vaccine Genes by Merging Mutations from Different Variants of Concern
Susanne Herwig, Julia M. Adler, Daria Vladimirova, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 248-248
Open Access
Susanne Herwig, Julia M. Adler, Daria Vladimirova, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 248-248
Open Access
Comparing Neutralizing Antibody Activity Over Time Between Naive and Convalesced COVID-19 Vaccinated Individuals
Lisette de Pillis, Rebecca Caffrey, Ge Che, et al.
Research Square (Research Square) (2024)
Open Access
Lisette de Pillis, Rebecca Caffrey, Ge Che, et al.
Research Square (Research Square) (2024)
Open Access
Longitudinal Landscape Mapping of Neutralizing Antibodies Against Diverse SARS-CoV-2 Variants In Infected Population Reveals The Adaptive Evolution of Protective Immunity During 2020–2023
Yunhui Li, Xiaohan Zhang, Jingkun Yi, et al.
(2024)
Closed Access
Yunhui Li, Xiaohan Zhang, Jingkun Yi, et al.
(2024)
Closed Access
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses
Rafael Bayarri‐Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Rafael Bayarri‐Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Introduction, Spread and Impact of the SARS-CoV-2 Omicron Variants BA.1 and BA.2 in Cyprus
Jan Richter, Dana Koptides, Christina Tryfonos, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1688-1688
Open Access | Times Cited: 3
Jan Richter, Dana Koptides, Christina Tryfonos, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1688-1688
Open Access | Times Cited: 3
Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors
Binan Lu, Ka-Li Zhu, Xiao-Ming Cui, et al.
Clinical Immunology (2022) Vol. 244, pp. 109103-109103
Open Access | Times Cited: 3
Binan Lu, Ka-Li Zhu, Xiao-Ming Cui, et al.
Clinical Immunology (2022) Vol. 244, pp. 109103-109103
Open Access | Times Cited: 3
BNT162b2 Effectiveness and Durability Against BA.1 and BA.2 Hospital and Emergency Department Admissions in a Large US Health System: A Test-Negative Design
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 2
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 2
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Timothy A. Bates, Pei Lu, Ye jin Kang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination
Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 2, pp. 258.e1-258.e4
Open Access | Times Cited: 2
Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 2, pp. 258.e1-258.e4
Open Access | Times Cited: 2
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 2
Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 2
Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein
Jermilia Charles, Nathan R. McCann, Victoria A. Ploplis, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 641, pp. 61-66
Open Access | Times Cited: 2
Jermilia Charles, Nathan R. McCann, Victoria A. Ploplis, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 641, pp. 61-66
Open Access | Times Cited: 2
SARS‐CoV‐2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID‐19 due to Omicron BA.1 and BA.2
Paula de Michelena, Beatriz Olea, Ignacio Torres, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5836-5840
Open Access | Times Cited: 1
Paula de Michelena, Beatriz Olea, Ignacio Torres, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5836-5840
Open Access | Times Cited: 1
Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces
Ya‐Wen Hsiao, Tseden Taddese, Guadalupe Jiménez-Serratos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Ya‐Wen Hsiao, Tseden Taddese, Guadalupe Jiménez-Serratos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Tulio J. Lopera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Tulio J. Lopera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Breakthrough infection with Omicron subvariant BF.7 induces broadly neutralizing antibodies to SARS-CoV-2 variants including XBB lineage
Linqi Zhang, Qi Zhang, Peng Chen, et al.
Research Square (Research Square) (2023)
Open Access
Linqi Zhang, Qi Zhang, Peng Chen, et al.
Research Square (Research Square) (2023)
Open Access
Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth
Suprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access
Suprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access
Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis
Huichun Shi, Jiajia Sun, Yigang Zeng, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access
Huichun Shi, Jiajia Sun, Yigang Zeng, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access
Unraveling the Tapestry: Immune Imprinting Amidst a Spectrum of Challenges for modRNA COVID-19 Vaccines
Ronald palacios castrillo
(2023)
Open Access
Ronald palacios castrillo
(2023)
Open Access
A Modified Recombinant DNA-Based SARS-CoV-2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS-CoV-2 Variants of Concern
Rwaa H. Abdulal, Muhammad Yasir Khan, Najwa D. Aljehani, et al.
Transboundary and Emerging Diseases (2023) Vol. 2023, pp. 1-11
Open Access
Rwaa H. Abdulal, Muhammad Yasir Khan, Najwa D. Aljehani, et al.
Transboundary and Emerging Diseases (2023) Vol. 2023, pp. 1-11
Open Access
Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
Gemma E. Hartley, Emily S.J. Edwards, Nirupama Varese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Gemma E. Hartley, Emily S.J. Edwards, Nirupama Varese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
Carl Graham, Thomas Lechmere, Aisha Rehman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Carl Graham, Thomas Lechmere, Aisha Rehman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Ancestral SARS-CoV-2 driven antibody repertoire diversity in an unvaccinated individual correlates with expanded neutralization breadth
Suprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Suprit Deshpande, Mohammed Yousuf Ansari, Jyoti Sutar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Vaccine- and BTI-elicited pre-Omicron immunity more effectively neutralizes Omicron sublineages BA.1, BA.2, BA.4 and BA.5 than pre-Omicron infection alone
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
